Literature DB >> 6861069

The dedifferentiation of prostate carcinoma.

P N Brawn.   

Abstract

Fifty-four patients with prostate carcinoma, each having 2 TURP (transurethral resection of the prostate) procedures separated by 3 to 11 years, were studied to determine whether the histologic appearance of prostate carcinoma remains the same for the life of the host or whether the histological appearance changes with time. Using the M. D. Anderson (MDAH) method of grading prostate carcinoma, 19 of 26 (73%) Grade 1 lesions, 9 of 12 (75%) Grade 2 lesions, and 7 of 8 (88%) Grade 3 lesions dedifferentiated into another grade at the time of the 2nd TURP. Eight cases that were Grade 4 at the time of the 1st TURP, remained Grade 4 lesions at the time of the 2nd TURP. Although 10 Grade 1, Grade 2, and Grade 3 lesions did not change grades, 8 of these 10 cases were less differentiated at the time of the second TURP than they were at the time of the first TURP. Furthermore, no Grade 1 lesions demonstrated evidence of metastases, but 19% of Grade 2 lesions, 55% of Grade 3 lesions, and 80% of Grade 4 lesions demonstrated evidence of metastases. This study suggests that the usual course of prostate carcinoma is dedifferentiation and that with dedifferentiation, the likelihood of metastases increases.

Entities:  

Mesh:

Year:  1983        PMID: 6861069     DOI: 10.1002/1097-0142(19830715)52:2<246::aid-cncr2820520210>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  The metastatic potential of prostate carcinomas composed entirely of single malignant glands.

Authors:  P N Brawn; C F Johnson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

2.  Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.

Authors:  Anamay Shetty; Ji-Heui Seo; Connor A Bell; Edward P O'Connor; Mark M Pomerantz; Matthew L Freedman; Alexander Gusev
Journal:  Am J Hum Genet       Date:  2021-10-25       Impact factor: 11.025

3.  Diagnosis, prognosis and management of incidentally found prostate cancer.

Authors:  P J Davidson
Journal:  Urol Res       Date:  1993-01

4.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  The course of metastatic disease originating from carcinoma of the prostate.

Authors:  S Plesnicar
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

6.  Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.

Authors:  Todd B Sheridan; H Ballentine Carter; Wenle Wang; Patricia B Landis; Jonathan I Epstein
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

Review 7.  Mechanisms of tumor invasion: evidence from in vivo observations.

Authors:  H Gabbert
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

Authors:  A Berner; J M Nesland; H Waehre; J Silde; S D Fosså
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

9.  The dedifferentiation of metastatic prostate carcinoma.

Authors:  P N Brawn; V O Speights
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.